Literature DB >> 17626133

Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice.

Sebastian Albinsson1, Yulia Shakirova, Anna Rippe, Maria Baumgarten, Bert-Inge Rosengren, Catarina Rippe, Rupert Hallmann, Per Hellstrand, Bengt Rippe, Karl Swärd.   

Abstract

Caveolin-1 (Cav-1) is essential for the morphology of membrane caveolae and exerts a negative influence on a number of signaling systems, including nitric oxide (NO) production and activity of the MAP kinase cascade. In the vascular system, ablation of caveolin-1 may thus be expected to cause arterial dilatation and increased vessel wall mass (remodeling). This was tested in Cav-1 knockout (KO) mice by a detailed morphometric and functional analysis of mesenteric resistance arteries, shown to lack caveolae. Quantitative morphometry revealed increased media thickness and media-to-lumen ratio in KO. Pressure-induced myogenic tone and flow-induced dilatation were decreased in KO arteries, but both were increased toward wild-type (WT) levels following NO synthase (NOS) inhibition. Isometric force recordings following NOS inhibition showed rightward shifts of passive and active length-force relationships in KO, and the force response to alpha(1)-adrenergic stimulation was increased. In contrast, media thickness and force response of the aorta were unaltered in KO vs. WT, whereas lumen diameter was increased. Mean arterial blood pressure during isoflurane anesthesia was not different in KO vs. WT, but greater fluctuation in blood pressure over time was noted. Following NOS inhibition, fluctuations disappeared and pressure increased twice as much in KO (38 +/- 6%) compared with WT (17 +/- 3%). Tracer-dilution experiments showed increased plasma volume in KO. We conclude that NO affects blood pressure more in Cav-1 KO than in WT mice and that restructuring of resistance vessels and an increased responsiveness to adrenergic stimulation compensate for a decreased tone in Cav-1 KO mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626133     DOI: 10.1152/ajpregu.00092.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  27 in total

1.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

2.  Biomechanical properties and innervation of the female caveolin-1-deficient detrusor.

Authors:  Mardjaneh Karbalaei Sadegh; Mari Ekman; Catarina Rippe; Frank Sundler; Nils Wierup; Michiko Mori; Bengt Uvelius; Karl Swärd
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  Caveolin-1 facilitates the direct coupling between large conductance Ca2+-activated K+ (BKCa) and Cav1.2 Ca2+ channels and their clustering to regulate membrane excitability in vascular myocytes.

Authors:  Yoshiaki Suzuki; Hisao Yamamura; Susumu Ohya; Yuji Imaizumi
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

Review 4.  Caveolins and caveolae in ocular physiology and pathophysiology.

Authors:  Xiaowu Gu; Alaina M Reagan; Mark E McClellan; Michael H Elliott
Journal:  Prog Retin Eye Res       Date:  2016-09-21       Impact factor: 21.198

5.  Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.

Authors:  Luminita H Pojoga; Zuzana Adamová; Abhinav Kumar; Amanda K Stennett; Jose R Romero; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

6.  Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure.

Authors:  Leon J DeLalio; Alexander S Keller; Jiwang Chen; Andrew K J Boyce; Mykhaylo V Artamonov; Henry R Askew-Page; T C Stevenson Keller; Scott R Johnstone; Rachel B Weaver; Miranda E Good; Sara A Murphy; Angela K Best; Ellen L Mintz; Silvia Penuela; Iain A Greenwood; Roberto F Machado; Avril V Somlyo; Leigh Anne Swayne; Richard D Minshall; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

7.  Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.

Authors:  Luminita H Pojoga; Jose R Romero; Tham M Yao; Paul Loutraris; Vincent Ricchiuti; Patricia Coutinho; Christine Guo; Nathalie Lapointe; James R Stone; Gail K Adler; Gordon H Williams
Journal:  Endocrinology       Date:  2010-01-22       Impact factor: 4.736

8.  Atrap deficiency increases arterial blood pressure and plasma volume.

Authors:  Mona Oppermann; Bernhard Gess; Frank Schweda; Hayo Castrop
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

Review 9.  Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.

Authors:  Zeyad D Nassar; Michelle M Hill; Robert G Parton; Marie-Odile Parat
Journal:  Nat Rev Urol       Date:  2013-08-13       Impact factor: 14.432

10.  Arterial Wall Stiffening in Caveolin-1 Deficiency-Induced Pulmonary Artery Hypertension in Mice.

Authors:  J Moreno; D Escobedo; C Calhoun; C Jourdan Le Saux; H C Han
Journal:  Exp Mech       Date:  2020-10-14       Impact factor: 2.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.